GE HealthCare (GEHC) Misses Q1 EPS by 1c, reaffirms guidance

Go back to GE HealthCare (GEHC) Misses Q1 EPS by 1c, reaffirms guidance

BofA thinks the selloff in GE HealthCare (GEHC) may be overdone. Here's why

May 1, 2024 12:30 PM EDT

Following a surprising miss in revenue and earnings per share (EPS) for the first quarter, shares of GE HealthCare (NASDAQ: GEHC) experienced a significant downturn, plummeting over 14% on Tuesday. The miss, which caught investors off guard, was driven by unexpected disruptions in China and a more pronounced second half ramp.

Despite the... More

GE HealthCare (GEHC) PT Lowered to $96 at Evercore ISI

April 30, 2024 12:05 PM EDT

Evercore ISI analyst Vijay Kumar lowered the price target on GE HealthCare (NASDAQ: GEHC) to $96.00 (from $100.00) while maintaining a Outperform rating.

The analyst comments "GEHC reported org rev declines of -50 bps, with revs of $4.65 Bn coming in ~150M or 3% below ST. The miss was mainly driven by lower capital sales (MRI, CT, ultrasound & monitoring/vents) and was partly offset by better PDx. Geographically, the miss was driven by China as customers paused due to stimulus announcement. 1Q also had some order fulfillment issues in its PCS segment. On the positive side, GMs were up... More